# Neurocrine is paying $145,000 per patient for a drug that works - Date: 2026-04-06 - Category: Biotech & Life Sciences $2.9B for Soleno means $100K+ per patient annually, for a drug with no competition and 20,000 US patients. The access question is who absorbs that cost — and what happens when they cannot. ---